Lumos Diagnostics Holdings Ltd. (LDXHF) Stock Price & Analysis
LDXHF Stock Chart & Stats
- Day’s Range
- $0.05 - $0.06
- 52-Week Range
- $0.05 - $0.24
- Previous Close
- $0.05
- Volume
- N/A
- Average Volume (3M)
- 15.35K
- Market Cap
- $41.69M
- Enterprise Value
- $85.46M
- Total Cash (Recent Filing)
- $15.42M
- Total Debt (Recent Filing)
- $5.94M
- Price to Earnings (P/E)
- ―
- Beta
- 2.55
- Next Earnings
- Mar 04, 2027 (Est.)
- EPS Estimate
- -0.01
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth
Steady revenue growth indicates improving commercial traction for Lumos’s diagnostic products and services. If maintained, this expanding top line can support operating leverage, strengthen market presence, and provide a broader base from which the company can pursue future profitability.
Operating Cash Flow Improvement
The return to positive operating cash flow suggests better working-capital control or cost discipline and is an important improvement in the underlying operating cycle. Sustaining this progress could reduce reliance on external funding and improve flexibility while the business scales.
Manageable Absolute Debt
Modest absolute debt and positive reported equity indicate that Lumos is not balance-sheet insolvent and retains a foundation for continued operations. This provides more financial resilience than a heavily indebted structure, although improving profitability remains important to preserve that position.
Bears Say
Persistent Operating And Net Losses
Recurring operating and net losses show that revenue growth has not yet translated into a profitable business model. Continued losses can erode equity, constrain investment capacity, and make it harder for Lumos to fund product development and commercialization without outside capital.
Negative FY2026 Gross Profit
A negative gross profit is a serious deterioration in product or service economics, because direct revenue generation is not covering the associated costs. Unless reversed, this condition can undermine scalability, limit the benefit of revenue growth, and prolong the path to sustainable earnings.
Negative Free Cash Flow
Persistently negative free cash flow means the company is not yet consistently self-funding after investments and other cash needs. This increases dependence on financing or cash reserves, limits strategic flexibility, and leaves less capacity to absorb setbacks while profitability remains weak.
Lumos Diagnostics Holdings Ltd. News
LDXHF FAQ
What was Lumos Diagnostics Holdings Ltd.’s price range in the past 12 months?
What is Lumos Diagnostics Holdings Ltd.’s market cap?
When is Lumos Diagnostics Holdings Ltd.’s upcoming earnings report date?
How were Lumos Diagnostics Holdings Ltd.’s earnings last quarter?
Is Lumos Diagnostics Holdings Ltd. overvalued?
Does Lumos Diagnostics Holdings Ltd. pay dividends?
What is Lumos Diagnostics Holdings Ltd.’s EPS estimate?
How many shares outstanding does Lumos Diagnostics Holdings Ltd. have?
What happened to Lumos Diagnostics Holdings Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Lumos Diagnostics Holdings Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Lumos Diagnostics Holdings Ltd. Stock Smart Score
Lumos Diagnostics Holdings Ltd. (LDXHF) Earnings & Revenues
LDXHF Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 1 | 15 |
| Technical Analysis | 5 | 1 | 3 |
| Moving Averages | 0 | 0 | 12 |
